Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.
Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
Benzothiazole and stilbene derivatives as promising PET myelin radiotracers for multiple sclerosis.
U.S. Patent Office Declares an Interference Between Forward Pharma and Biogen Regarding the Treatment of Multiple Sclerosis With 480 mg Daily Dose of DMF, the Active Ingredient in Tecfidera(R)
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.
The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research.
Treatment satisfaction in multiple sclerosis.
Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis.
A randomized controlled phase II trial of riluzole in early multiple sclerosis.
Combined structural and functional patterns discriminating upper limb motor disability in multiple sclerosis using multivariate approaches.
Multiple sclerosis in pregnancy.
Gpr126 functions in Schwann cells to control differentiation and myelination via G-protein activation.
Interferon beta-1b-induced Sweet's syndrome in a patient with multiple sclerosis.
SigmaPharm Laboratories Products
Spectrum of nontraumatic myelopathies in Ethiopian patients: hospital-based retrospective study.
Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination.
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis.
Risks of immune system treatments.
Site-Specific PEGylation Enhances the Pharmacokinetic Properties and Antitumor Activity of Interferon Beta-1b.
The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.
Nanoparticle transport across the blood brain barrier.
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage.

Pages